down arrow

Envoy Medical, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29415V1098
USD
0.70
-0.02 (-2.6%)

Dec 17

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.700.74

52 Week

0.642.00
Valuation
Technical
Day's Volume

CASH

22.16 k

Shareholding (Mar 2025)

FII

0.50%

Held by 6 FIIs

DII

94.22%

Held by 3 DIIs

Promoter

2.61%

What does Envoy Medical, Inc. do?

22-Jun-2025

Envoy Medical, Inc. is a Micro Cap company in the Pharmaceuticals & Biotechnology industry. It has a market cap classified as Micro Cap, with no dividend yield and negative financial metrics.

Overview: <BR>Envoy Medical, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>Financial Snapshot: <BR>Market cap: Micro Cap<BR><BR>Key Metrics: <BR>Industry: Pharmaceuticals & Biotechnology <BR>Dividend Yield: 0.00% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: -999,999.00% <BR>Price to Book: 0.00 <BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Envoy Medical, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, Envoy Medical, Inc. shows a mildly bearish technical trend with mixed signals across time frames, underperforming the S&P 500 with a year-to-date return of -4.2% and a one-year return of -55.95%.

As of 11 September 2025, the technical trend for Envoy Medical, Inc. has changed from bearish to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance, indicating mixed signals across time frames. The Bollinger Bands are mildly bearish on both weekly and monthly charts, and daily moving averages are bearish, further supporting a cautious outlook. The KST is bearish across both weekly and monthly periods, and while the OBV is bullish monthly, it shows no trend weekly. <BR><BR>In terms of performance, the stock has underperformed compared to the S&P 500, with a year-to-date return of -4.2% versus 12.22% for the index, and a one-year return of -55.95% compared to 17.14% for the S&P 500. Overall, the current technical stance is mildly bearish, reflecting a weak recovery potential.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 28 Million ()

stock-summary
P/E

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.77

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

-0.94

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-46.74%
0%
-46.74%
6 Months
-49.79%
0%
-49.79%
1 Year
-63.0%
0%
-63.0%
2 Years
-71.31%
0%
-71.31%
3 Years
-92.96%
0%
-92.96%
4 Years
-92.79%
0%
-92.79%
5 Years
0%
0%
0.0%

Envoy Medical, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Envoy Medical, Inc. technically bullish or bearish?

As of 11 September 2025, the technical trend for Envoy Medical, Inc. has changed from bearish to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance, indicating mixed signals across time frames. The Bollinger Bands are mildly bearish on both weekly and monthly charts, and daily moving averages are bearish, further supporting a cautious outlook. The KST is bearish across both weekly and monthly periods, and while the OBV is bullish monthly, it shows no trend weekly. In terms of performance, the stock has underperformed compared to the S&P 500, with a year-to-date return of -4.2% versus 12.22% for the index, and a one-year return of -55.95% compared to 17.14% for the S&P 500. Overall, the current technical stance is mildly bearish, reflecting a weak recovery potential....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.85%
EBIT Growth (5y)
-203.36%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
25.94%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
EV to EBITDA
EV to Capital Employed
EV to Sales
PEG Ratio
NA
Dividend Yield
ROCE (Latest)
ROE (Latest)
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 5 Schemes (2.67%)

Foreign Institutions

Held by 6 Foreign Institutions (0.5%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -46.15% vs -254.55% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.00",
          "val2": "-4.80",
          "chgp": "-4.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.10",
          "chgp": "500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1.00",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.70",
          "val2": "-3.90",
          "chgp": "-46.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-65,000.00%",
          "val2": "-71,470.60%",
          "chgp": "647.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -33.33% vs 50.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 24.75% vs -88.05% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-19.10",
          "val2": "-18.20",
          "chgp": "-4.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "-11.60",
          "chgp": "93.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-22.50",
          "val2": "-29.90",
          "chgp": "24.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-85,582.20%",
          "val2": "-58,098.10%",
          "chgp": "-2,748.41%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.10
0.10
Operating Profit (PBDIT) excl Other Income
-5.00
-4.80
-4.17%
Interest
0.60
0.10
500.00%
Exceptional Items
0.00
1.00
-100.00%
Consolidate Net Profit
-5.70
-3.90
-46.15%
Operating Profit Margin (Excl OI)
-65,000.00%
-71,470.60%
647.06%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -46.15% vs -254.55% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.20
0.30
-33.33%
Operating Profit (PBDIT) excl Other Income
-19.10
-18.20
-4.95%
Interest
0.80
0.00
Exceptional Items
-0.70
-11.60
93.97%
Consolidate Net Profit
-22.50
-29.90
24.75%
Operating Profit Margin (Excl OI)
-85,582.20%
-58,098.10%
-2,748.41%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -33.33% vs 50.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 24.75% vs -88.05% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Envoy Medical, Inc. stock-summary
stock-summary
Envoy Medical, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."